Maternal Morbidity After Double Balloon Catheter Management of Cesarean Scar and Cervical Pregnancies.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 36357970.
- Also identified by DOI 10.1097/AOG.0000000000004977.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed a retrospective cohort study of all Type 1 cesarean scar pregnancies (n=18) or cervical pregnancies (n=5) at an academic tertiary center after treatment with a cervical double balloon catheter from 2018 to 2022 to evaluate outcomes and maternal morbidity. Cervical double balloon catheter treatment was associated with no cases (95% confidence interval 0-16%) of maternal hemorrhage treated with transfusion, hysterectomy, or ICU admission. Treatment was successfully performed by nine different obstetrics and gynecology specialists.
Medical subject headings
- Cicatrix
- Pregnancy, Ectopic